James Breitmeyer

(Dr. James Breitmeyer M.D., Ph.D.)

Currently holds positions in Zogenix Inc and Oncternal Therapeutics Inc

Positions

Position Company Period
Independent Director Zogenix Inc Jan. 1, 2017 -
President, Chief Executive Officer Oncternal Therapeutics Inc June 7, 2019 -
Director Zogenix Inc March 25, 2014 - Jan. 1, 2017
James Breitmeyer's trades of Oncternal Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-04-17 2023-04-14
B Purchase
2,250 +1.2%
0.29
USD 653 		2,250 +1.2% 0.29 USD 653
2023-04-17 2023-04-14
B Purchase
47,750 +32.6%
0.30
USD 14,277 		47,750 +32.6% 0.30 USD 14,277
2023-04-17 2023-04-13
B Purchase
100,000 +214.9%
0.29
USD 29,000 		100,000 +214.9% 0.29 USD 29,000
2022-01-31 2022-01-27
B Purchase
25,000 +116.0%
1.68
USD 42,080 		25,000 +116.0% 1.68 USD 42,080
2019-11-27 2019-11-25
US Zogenix Inc (ZGNX)
PS Planned sale
5,000 -80.0%
50.00
USD 250,000 		5,000 -80.0% 50.00 USD 250,000
// ... existing code ... // ... rest of the file ...